THC for Cannabis Drug Effects

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Cannabis Drug EffectsTHC - Drug
Eligibility
18 - 55
All Sexes
What conditions do you have?
Select

Study Summary

This trial will give cannabidiol to people to see if it is effective and safe.

Eligible Conditions
  • Cannabis Drug Effects

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 3 Secondary · Reporting Duration: Day 1, 2, 7, 14, and 21

Day 1
Blood cannabinoids
Oral Fluid cannabinoids
Urine cannabinoids
Day 21
Subjective drug effects as assessed by the Drug Effect Questionnaire

Trial Safety

Safety Progress

1 of 3

Trial Design

3 Treatment Groups

CBD with 3.7 mg THC
1 of 3
CBD without THC
1 of 3
CBD with 2.8 mg THC
1 of 3

Experimental Treatment

120 Total Participants · 3 Treatment Groups

Primary Treatment: THC · No Placebo Group · Phase 1

CBD with 3.7 mg THCExperimental Group · 2 Interventions: THC, CBD · Intervention Types: Drug, Drug
CBD without THC
Drug
Experimental Group · 1 Intervention: CBD · Intervention Types: Drug
CBD with 2.8 mg THCExperimental Group · 2 Interventions: THC, CBD · Intervention Types: Drug, Drug
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
THC
2017
Completed Phase 1
~290
Cannabidiol
FDA approved

Trial Logistics

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: day 1, 2, 7, 14, and 21

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,073 Previous Clinical Trials
31,017,105 Total Patients Enrolled
Ryan Vandrey, PhDPrincipal InvestigatorJohns Hopkins University
11 Previous Clinical Trials
387 Total Patients Enrolled

Eligibility Criteria

Age 18 - 55 · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
Maryland100.0%
How old are they?
18 - 65100.0%
What site did they apply to?
Johns Hopkins University100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%